Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott McHenry

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Gastroenterology|May 5, 2023
The evaluation of liver abnormalities in inflammatory bowel disease patientsScott McHenry
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 27, 2021
Validation of the Dallas Steatosis Index to Predict Nonalcoholic Fatty Liver Disease in the UK Biobank PopulationScott McHenry, Yikyung Park, Nicholas O Davidson
Digestive Diseases and Sciences|June 8, 2023
Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic SteatosisScott McHenry, Ameen Awad, Julia Kozlitina, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 27, 2020
Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver DiseaseScott McHenry, Yikyung Park, Jeffrey D Browning, et al.
The American Journal of Gastroenterology|December 24, 2024
Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel DiseaseScott R Anderson, Malek Ayoub, Sarah Coats, et al.
Crohn'S & Colitis 360|February 27, 2023
Nonalcoholic Fatty Liver Disease Is a Risk Factor for Thiopurine Hepatotoxicity in Crohn's DiseaseAlvin T George, Matthew Glover, Quazim Alayo, et al.
Inflammatory Bowel Diseases|July 16, 2023
NAFLD Is Associated With Quiescent Rather Than Active Crohn's DiseaseScott McHenry, Matthew Glover, Ali Ahmed, et al.
Bioengineering (Basel, Switzerland)|June 27, 2024
Quantification of Visceral Fat at the L5 Vertebral Body Level in Patients with Crohn's Disease Using T2-Weighted MRIFavour Garuba, Aravinda Ganapathy, Spencer McKinley, et al.
Inflammatory Bowel Diseases|January 8, 2020
Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's DiseaseScott McHenry, Ankita Tirath, Richard Tsai, et al.
Hepatology Communications|October 12, 2022
Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancersScott McHenry, Xiaoyu Zong, Mengyao Shi, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Gastroenterology|May 5, 2023
The evaluation of liver abnormalities in inflammatory bowel disease patientsScott McHenry
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 27, 2021
Validation of the Dallas Steatosis Index to Predict Nonalcoholic Fatty Liver Disease in the UK Biobank PopulationScott McHenry, Yikyung Park, Nicholas O Davidson
Digestive Diseases and Sciences|June 8, 2023
Low LDL Cholesterol Is Not an Independent Risk Factor for Hepatic SteatosisScott McHenry, Ameen Awad, Julia Kozlitina, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 27, 2020
Dallas Steatosis Index Identifies Patients With Nonalcoholic Fatty Liver DiseaseScott McHenry, Yikyung Park, Jeffrey D Browning, et al.
The American Journal of Gastroenterology|December 24, 2024
Safety and Effectiveness of Glucagon-like Peptide-1 Receptor Agonists in Inflammatory Bowel DiseaseScott R Anderson, Malek Ayoub, Sarah Coats, et al.
Crohn'S & Colitis 360|February 27, 2023
Nonalcoholic Fatty Liver Disease Is a Risk Factor for Thiopurine Hepatotoxicity in Crohn's DiseaseAlvin T George, Matthew Glover, Quazim Alayo, et al.
Inflammatory Bowel Diseases|July 16, 2023
NAFLD Is Associated With Quiescent Rather Than Active Crohn's DiseaseScott McHenry, Matthew Glover, Ali Ahmed, et al.
Bioengineering (Basel, Switzerland)|June 27, 2024
Quantification of Visceral Fat at the L5 Vertebral Body Level in Patients with Crohn's Disease Using T2-Weighted MRIFavour Garuba, Aravinda Ganapathy, Spencer McKinley, et al.
Inflammatory Bowel Diseases|January 8, 2020
Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's DiseaseScott McHenry, Ankita Tirath, Richard Tsai, et al.
Hepatology Communications|October 12, 2022
Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancersScott McHenry, Xiaoyu Zong, Mengyao Shi, et al.
Pageof 2